Abstract:Many pharmacokinetic analyses require unbound plasma concentrations, including prediction of clearance, volume of distribution, drug-drug interactions, brain uptake analysis, etc. It is most often more convenient to measure the total drug concentration in plasma rather than the unbound drug concentration. To arrive at unbound plasma concentrations, separate in vitro determinations of the plasma protein binding of a drug are usually carried out in serum or in plasma, and the plasma pharmacokinetic results are then mathematically adjusted by this fraction unbound ( f u,p). Plasma protein binding or the drug fraction unbound in plasma ( f u,p) is known to be affected by protein, drug, free fatty acid concentrations, lipoprotein partitioning, temperature, pH, and the presence or absence of other drugs/displacing agents within plasma samples. Errors in f u,p determination caused by lack of adequate pH control in newer assay formats for plasma protein binding (e.g., 96-well equilibrium thin walled polypropylene dialysis plates) will have significant drug-specific impact on these pharmacokinetic calculations. Using a diverse set of 55 drugs and a 96-well equilibrium dialysis plate format, the effect of variable pH during equilibrium dialysis experiments on measured values of f u,p was examined. Equilibrium dialysis of human plasma against Dulbecco's phosphate buffered saline at 37 degrees C under an air or 10% CO 2 atmosphere for 22 h resulted in a final pH of approximately 8.7 and 7.4, respectively. The ratio of f u,p at pH 7.4 (10% CO 2) vs pH 8.7 (air) was >or=2.0 for 40% of the 55 compounds tested. Only one of the 55 compounds tested had a ratio <0.9. Select compounds were further examined in rat and dog plasma. In addition, physicochemical properties were calculated for all compounds using ACD/Labs software or Merck in-house software and compared to plasma protein binding results. Changes in plasma protein binding due to pH increases which occurred during the equilibrium dialysis experiment were not species specific but were drug-specific, though nonpolar, cationic compounds had a higher likely hood of displaying pH-dependent binding. These studies underscore the importance of effectively controlling pH in plasma protein binding studies.

Protein binding study of acid drug N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine in human plasma albumin solution by high performance capillaryelectrophoresis frontal analysis

Assay of Fexofenadine Concentrations in Human Plasma by HPLC with Fluorescence Detector

Study on Antibody Adsorption and Elution Performance of Carboxyl and Hydrophobic Groups on Mixed-Mode Ligands

Stereoselective protein binding studies of 2-(2-hydroxypropanamido) benzoic acid enantiomers in rat, beagle dog and human plasma

Determination of Binding Constants for Basic Drugs with Serum Albumin by Affinity Capillary Electrophoresis with the Partial Filling Technique

Detection of heterogeneous drug-protein binding by frontal analysis and high-performance affinity chromatography

STUDY ON ASSAY OF DICLOFENAC POTASSIUM IN HUMAN PLASMA

Determination of mycophenolic acid concentration in human plasma by high performance liquid chromatography with fluorescence detection

Ultrafiltration binding analyses of glycated albumin with a 3D-printed syringe attachment

Analysis of Flurbiprofen, Ketoprofen and Etodolac Enantiomers by Pre-Column Derivatization RP-HPLC and Application to Drug–protein Binding in Human Plasma

Testing for drug-human serum albumin binding using fluorescent probes and other methods

Simple Method Provides Resolution of Albumin, Lipoprotein, Free Fraction, and Chylomicron To Enhance the Utility of Protein Binding Assays

Determination of theophylline in plasma by high performance capillary electrophoresis

Analysis of Chiral Non-Steroidal Anti-Inflammatory Drugs Flurbiprofen, Ketoprofen and Etodolac Binding with HSA

Characterization of plasma protein binding dissociation with online SPE-HPLC

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Approaches to the Study of N-Linked Glycoproteins in Human Plasma Using Lectin Affinity Chromatography and Nano-Hplc Coupled to Electrospray Linear Ion Trap-Fourier Transform Mass Spectrometry

Capillary Electrophoresis‐Frontal Analysis (CE‐FA) and Molecular Docking Studies on the Albumin‐Binding Properties of Dopamine and Serotonin

Structural Basis of the Drug-binding Specificity of Human Serum Albumin

Simultaneous determination of aromatic amino acids in human blood plasma by capillary electrophoresis with UV-absorption detection

Impact of pH on Plasma Protein Binding in Equilibrium Dialysis